{"DataElement":{"publicId":"7135791","version":"1","preferredName":"Central Pathology Review Biospecimen Histologic Grade","preferredDefinition":"The assignment of a position on a scale of quality to describe the microscopic physical features of cells by a central lab using standardized methods and result criteria.","longName":"7135767v1.0:7135768v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7135767","version":"1","preferredName":"Central Pathology Review Biospecimen","preferredDefinition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"2932507v1.0:3004967v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"2932507","version":"1","preferredName":"Central Pathology Review","preferredDefinition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","longName":"C71684","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Pathology Review","conceptCode":"C71684","definition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70F92978-F233-DCBE-E040-BB89AD4311A0","latestVersionIndicator":"Yes","beginDate":"2009-08-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-12","modifiedBy":"ONEDATA","dateModified":"2009-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3004967","version":"1","preferredName":"Biospecimen","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E53DD71-5644-E092-E040-BB89AD436E56","latestVersionIndicator":"Yes","beginDate":"2010-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-29","modifiedBy":"ONEDATA","dateModified":"2010-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BBB077B-EEA7-287D-E053-F662850A51B6","latestVersionIndicator":"Yes","beginDate":"2020-01-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"KNABLEJ","dateModified":"2020-02-12","changeDescription":"2/12/20 jk CPTAC/Linda approved CDE; AI released, RS chg to Qualified.    1/9/20 jk created for CPTAC Path Review CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7135768","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A position on a scale of intensity or amount or quality.","longName":"7135768v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"GX","valueDescription":"Grade X","ValueMeaning":{"publicId":"5210903","version":"1","preferredName":"Grade X","longName":"5210903","preferredDefinition":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Grade X","conceptCode":"C113730","definition":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2FC19F3A-FBBE-BEEA-E050-BB89AD436723","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"LISU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BBB3708-11BB-3247-E053-F662850A5635","beginDate":"2020-01-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"},{"value":"G4","valueDescription":"Undifferentiated","ValueMeaning":{"publicId":"5428031","version":"1","preferredName":"Undifferentiated","longName":"5428031","preferredDefinition":"A term used to describe cells or tissues that do not have specialized (\"mature\") structures or functions. Undifferentiated cancer cells often grow and spread quickly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AAEF41A-81D2-3BA9-E050-BB89AD435B01","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-08-22","modifiedBy":"LISU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BBB3708-11D0-3247-E053-F662850A5635","beginDate":"2020-01-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"},{"value":"G1","valueDescription":"Well Differentiated","ValueMeaning":{"publicId":"3685458","version":"1","preferredName":"Well Differentiated","longName":"3685458v1.00","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A18-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BBB3708-11DB-3247-E053-F662850A5635","beginDate":"2008-09-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"},{"value":"G2","valueDescription":"Moderately Differentiated","ValueMeaning":{"publicId":"2559269","version":"1","preferredName":"Moderately Differentiated","longName":"2559269v1.00","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B492-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BBB3708-11E6-3247-E053-F662850A5635","beginDate":"2008-09-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"},{"value":"G3","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"3685459","version":"1","preferredName":"Poorly Differentiated","longName":"3685459","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A3B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BBB3708-11F1-3247-E053-F662850A5635","beginDate":"2008-09-18","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2786701","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Of or relating to histology.:A position on a scale of intensity or amount or quality.","longName":"C25526:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57451CD6-05F6-28B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-19","modifiedBy":"ONEDATA","dateModified":"2008-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BBB3708-11A3-3247-E053-F662850A5635","latestVersionIndicator":"Yes","beginDate":"2020-01-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"SOKKERL","dateModified":"2021-05-12","changeDescription":"2/12/20 jk CPTAC/Linda approved CDE; AI released, RS chg to Qualified.  1/9/20 jk created for CPTAC Path Report CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779568","version":"1","longName":"STAD Pathology Review","context":"OCCPR"},{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779576","version":"1","longName":"UVM Pathology Review","context":"OCCPR"},{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"},{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779540","version":"1","longName":"CHOL Pathology Review","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"},{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779555","version":"1","longName":"ESCA Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Grade","type":"Preferred Question Text","description":"Histologic Grade","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BBC0972-6A8B-49E6-E053-F662850A6936","latestVersionIndicator":"Yes","beginDate":"2020-01-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-09","modifiedBy":"KNABLEJ","dateModified":"2020-02-12","changeDescription":"2/12/20 jk CPTAC/Linda approved CDE; AI released, RS chg to Qualified.    2/10/20 jk remove Local Path CSI references; Local Path should use CDE 7165774.  1/9/20 jk created for CPTAC Path Rpt CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}